LRRK2 and Parkinson disease: Our current knowledge of the molecular mechanisms of PD pathogenesis largely derives from familial forms, which are caused by recessive mutations, such as in PARKIN and PINK1, as well as dominant mutations, including in SNCA and LRRK2 [47].